Oncology

The results of an MRI-based study show that patients with squamous cell cervical cancer with unclear tumor borders have a worse prognosis, lymph node metastases, and distant recurrence. One of the most common forms of cancer among women is cervical cancer. About 10,000 Japanese women are diagnosed with cervical cancer annually, and approximately 3,000 will...

To minimize breast and cervical cancer diagnoses and fatalities, communities should eliminate barriers, promote motivators, and increase access to supporting screening services, according to a recent study. Breast and cervical cancer rates are high among women in the United States. Lung cancer is the primary cause of cancer-related deaths in US women, with breast cancer...

Pediatric patients with Hodgkin lymphoma should be treated according to risk- and response-adaptive care principles, according to a recent study. Hodgkin lymphoma (HL) is the most prevalent cancer in young adults, making up about 40% of all lymphomas in children. HL is also one of the most treatable cancers, with about an 80% cure rate...

Elranatamab demonstrated substantial and enduring responses with a favorable safety profile in patients with relapsed or refractory multiple myeloma in a phase 3 trial. Transitioning to a biweekly dosing regimen could improve safety outcomes in the long term while still ensuring the maintenance of therapeutic effectiveness. Elranatamab is a humanized bispecific antibody that targets both...

No significant differences were found in plasma cell leukemia outcomes among racial groups of hospitalized patients in a recent study. Plasma cell leukemia (PCL) is an aggressive subtype of multiple myeloma (MM) with a poor prognosis. Prior studies have documented racial disparities among MM patients regarding prevalence, treatment outcomes, and mortality, but limited data exists...

A recent study found that higher side-effect bother was related to worse health-related quality of life in multiple myeloma patients. The study also found patient–physician discordance in reporting of side effects. Multiple myeloma (MM) is the second most prevalent hematological malignancy in the United States. Evidence shows that physicians focus on survival outcomes when making...

Intensity-modulated radiation therapy spares more normal tissue than 3D-conformal radiotherapy Intensity-modulated radiation therapy (IMRT) shows benefits over 3D-conformal (3D-CRT) radiotherapy for patients with locally advanced non-small cell lung cancer (NSCLC), according to a study presented at the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer, held from Sept. 9...

Staff Writer: Andre McGowan Although relative dose intensity similar, pathologic complete response higher with intervention A home-based diet and exercise intervention could improve outcomes for women undergoing chemotherapy for breast cancer, according to a study published online Sept. 1 in the Journal of Clinical Oncology. Tara Sanft, M.D., from Yale University in New Haven, Connecticut, and...

The field of multiple myeloma (MM) treatment has seen significant advancements in recent years, which have improved median survival rates for patients from 3 years two decades ago to around 10 years now. One of the most notable advancements in the treatment of MM is the introduction of immune-based therapies, specifically anti-CD38 monoclonal antibodies. These...